Adaptive Interventions for Emergency Department Patients With Opioid Use Disorder

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorRAND

About this trial

The ADAPT-ED study is a two-stage, sequential multiple assignment randomized trial (SMART) to inform the development of an adaptive intervention that is optimally effective in increasing long-term buprenorphine use for adults presenting to the ED with probable opioid use disorder (OUD).

Eligibility criteria

Qualifiers

Presented for ED care at ARMC

Age 18 or older

Probable OUD diagnosis

Speak and understand English or Spanish

Disqualifiers

None

Trial design

Treatments tested in this trial

  • SUN
  • SUN + Telebridge
  • ED-ITT
  • ED-ITT + BHS

Treatment groups

500 Participants
are divided into 6 treatment groups

6

Treatment groups

See each treatment group below.

Sponsors and collaborators

RAND

Lead sponsor

Arrowhead Regional Medical Center

Collaborator

Alameda Health System

Collaborator

Stanford University

Collaborator